What Next for Pfizer's Medical Device Business
It didn't take a crystal ball to foresee Pfizer's recent announcement that it is looking to exit the medical device business. But the question is, How? Finding a buyer for its diverse cardiovascular, orthopedics and urological businesses is slim. The concensus among industry executives: Pfizer will try spinning the businesses out into a public corporation, following a strategy Lilly used very successfully with Guidant Corp.
You may also be interested in...
The US FDA and NIST have agreed to help industry modernize and update pharmaceutical manufacturing methods and to improve supply chain resilience.
Medtronic is sponsoring a trial to evaluate its adaptive deep brain stimulation technology, a unique feature of the Percept PC device for treating Parkinson’s disease.
The company cited lackluster efficacy in its decision to discontinue development of V590 and V591. It will instead develop two drugs to treat COVID-19.